News

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the renewable energy industry, including EnerSys (NYSE:ENS) and its peers.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at building materials stocks, starting with Carlisle (NYSE:CSL).

Shareholders of Ingram Micro would probably like to forget the past six months even happened. The stock dropped 33.8% and now trades at $16.29. This was partly due to its softer quarterly results and might have investors contemplating their next move.

The funding round takes Auradine's total backing to $300 million.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Keurig Dr Pepper (NASDAQ:KDP) and the best and worst performers in the beverages, alcohol, and tobacco industry.

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the online marketplace industry, including Sea (NYSE:SE) and its peers.

Let’s dig into the relative performance of Hims & Hers Health (NYSE:HIMS) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.

Looking back on traditional fast food stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Yum! Brands (NYSE:YUM) and its peers.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at outpatient & specialty care stocks, starting with Select Medical (NYSE:SEM).

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Rivian (NASDAQ:RIVN) and its peers.